“An individual patient data analysis of almost 25,000 pregnancies in women living with HIV has found that the rate of birth defects following exposure to efavirenz was not statistically different, and may even be lower than in infants exposed to other antiretrovirals. The analysis by Professor Begoña Martinez de Tejada of the University of Geneva and colleagues is published in the Journal of Acquired Immunity Deficiency Syndromes.”
For more, click here.